Work

Abstract PS5-02-22: Impact of overall survival on the use of prophylactic granulocyte colony-stimulating factor with sacituzumab govitecan-hziy in the treatment of triple negative metastatic breast cancer patients

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-02-22

Authors: F. Kudrik, R. Choksi, V. Gorantla, S. Reddy, S. Reganti, S. Rosenfeld, G. Cioffi, E. Alwon, D. Parris, A. Rui, M. Gart, C. Wall, B. Wang, P. Varughese, J. Donegan, L. Morere, R. Geller, J. Scott, D. Patt

Institutions: South Carolina Oncology Associates, University of Pittsburgh Medical Center, Highlands Oncology Group, Integra (United States), Texas Oncology

Language: English

Topic: Neutropenia and Cancer Infections

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129201067

Cites:

Cited by:

Related to: